Electromed (ELMD) Liabilities and Shareholders Equity (2011 - 2026)
Electromed's (ELMD) quarterly Liabilities and Shareholders Equity came in at $59.5 million in Q1 2026, up 13.39% year-on-year from $52.5 million in Q1 2025, and up 8.31% on a QoQ basis from $54.9 million in Q4 2025.
Electromed (ELMD) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
Electromed (ELMD) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $59.5 million in Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity rose 13.39% year-over-year to $59.5 million in Q1 2026; TTM through Mar 2026 was $221.8 million, a 7.74% increase from a year earlier, with the FY2025 full-year figure at $53.8 million, up 3.0% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $59.5 million, up from $54.9 million in the prior quarter.
- Over the last five years, Liabilities and Shareholders Equity for ELMD reached as high as $59.5 million in Q1 2026 and fell as low as $39.0 million in Q1 2022.
- Historically, Liabilities and Shareholders Equity has averaged $48.1 million across 5 years, with a median of $48.9 million in 2024.
- Across the five-year window, Liabilities and Shareholders Equity grew 14.15% in 2024 and increased 3.0% in 2025, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $41.4 million in 2022, then grew by 13.46% to $47.0 million in 2023, then climbed by 11.31% to $52.3 million in 2024, then rose by 5.04% to $54.9 million in 2025, then increased by 8.31% to $59.5 million in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $59.5 million in Q1 2026, $54.9 million in Q4 2025, and $53.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.92 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.46 Bn |
| 10 | Electromed | 313.26 Mn | 296.27 Mn | 14.64 Mn | 59.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.47 Mn |
| Dec 31, 2025 | 54.91 Mn |
| Sep 30, 2025 | 53.61 Mn |
| Jun 30, 2025 | 53.80 Mn |
| Mar 31, 2025 | 52.45 Mn |
| Dec 31, 2024 | 52.27 Mn |
| Sep 30, 2024 | 48.92 Mn |
| Jun 30, 2024 | 52.23 Mn |
| Mar 31, 2024 | 48.90 Mn |
| Dec 31, 2023 | 46.96 Mn |
| Sep 30, 2023 | 44.07 Mn |
| Jun 30, 2023 | 45.81 Mn |
| Mar 31, 2023 | 42.84 Mn |
| Dec 31, 2022 | 41.39 Mn |
| Sep 30, 2022 | 40.13 Mn |
| Jun 30, 2022 | 41.36 Mn |
| Mar 31, 2022 | 39.02 Mn |
| Dec 31, 2021 | 38.20 Mn |
| Sep 30, 2021 | 37.90 Mn |
| Jun 30, 2021 | 37.11 Mn |